Advertisement
<< Back To Article
CAR-T Therapy: Lifeline to A Cure?

Write a Comment

I have read and agree to the terms and conditions in the Posting Rules*

1 Comments

wmay13241

My wife has (had?) aggressive follicular lymphoma. Within 4 years she progressed after R-CHOP, BR, Ibrutinib, and Idelalisib/rituximab. In March 2016 at the age of 69 she had a NIH CAR-T infusion. She has been in complete remission for 31 months. In the NIH hospital her only side effect was low blood pressure for 2 days. At day 3 she was exercising in the NIH gym. Her only remaining side effect is low immunoglobulins for which she receives when her IgG falls below 400 - about every 4 months.

October 17, 2018 Woodbridge, VA


Hot topics


Cancer Health uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy

Manage

Cancer Health uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.